Detalhe da pesquisa
1.
[Weaning Unit of the University Medicine Greifswald - Institutional Structure and Weaning Results from Prolonged Ventilation over 10 Years]. / Weaningzentrum Greifswald Struktur und Ergebnisse bei der Entwöhnung von der Langzeitbeatmung über zehn Jahre.
Pneumologie
; 71(8): 514-524, 2017 Aug.
Artigo
em Alemão
| MEDLINE | ID: mdl-28505685
2.
[Lung Health Data of the Study of Health in Pomerania - a Review of Samples, Methods and First Results]. / Pneumologisch relevante Daten aus der "Study of Health in Pomerania" (SHIP) eine Übersicht zu den Kohorten, Methoden und ersten Ergebnissen.
Pneumologie
; 71(1): 17-35, 2017 Jan.
Artigo
em Alemão
| MEDLINE | ID: mdl-28114706
3.
[Progressive multifocal leukoencephalopathy]. / Progressive multifokale Leukenzephalopathie.
Nervenarzt
; 87(12): 1300-1304, 2016 Dec.
Artigo
em Alemão
| MEDLINE | ID: mdl-27730274
4.
[Monitoring of blood parameters under course-modified MS therapy : Substance-specific relevance and current recommendations for action]. / Monitoring von Blutparametern unter verlaufsmodifizierender MS-Therapie : Substanzspezifische Relevanz und aktuelle Handlungsempfehlungen.
Nervenarzt
; 87(6): 645-59, 2016 Jun.
Artigo
em Alemão
| MEDLINE | ID: mdl-26927677
5.
Clearance of JC polyomavirus from cerebrospinal fluid following treatment with interleukin-2 and pembrolizumab in an individual with progressive multifocal leukoencephalopathy and no underlying immune deficiency syndrome.
Eur J Neurol
; 27(11): 2375-2377, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32644211
6.
[Pegylated interferon beta 1a. A new therapy option for treatment of relapsing-remitting multiple sclerosis]. / Pegyliertes Interferon-beta 1a. Eine neue Therapieoption zur Behandlung der schubförmigen multiplen Sklerose.
Nervenarzt
; 86(4): 483-90, 2015 Apr.
Artigo
em Alemão
| MEDLINE | ID: mdl-25833401
7.
[Teriflunomide for treatment of multiple sclerosis]. / Teriflunomid zur Behandlung der Multiplen Sklerose.
Nervenarzt
; 84(6): 724-31, 2013 Jun.
Artigo
em Alemão
| MEDLINE | ID: mdl-23695001
8.
[The Study of Health in Pomerania (SHIP) reference values for cardiopulmonary exercise testing]. / Referenzwerte für die Spiroergometrie - Ergebnisse der Study of Health in Pomerania (SHIP).
Pneumologie
; 67(1): 58-63, 2013 Jan.
Artigo
em Alemão
| MEDLINE | ID: mdl-23247595
9.
Airflow limitation, lung volumes and systemic inflammation in a general population.
Eur Respir J
; 39(1): 29-37, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21719491
10.
[Cannabinoids for symptomatic therapy of multiple sclerosis]. / Cannabinoide zur symptomatischen Therapie der Multiplen Sklerose.
Nervenarzt
; 83(6): 695-704, 2012 Jun.
Artigo
em Alemão
| MEDLINE | ID: mdl-22080198
11.
[Alemtuzumab: a further option for treatment of multiple sclerosis]. / Alemtuzumab: eine weitere Chance zur Therapie der Multiplen Sklerose.
Nervenarzt
; 83(4): 487-501, 2012 Apr.
Artigo
em Alemão
| MEDLINE | ID: mdl-22038387
12.
German guideline for diagnosis and treatment of multiple sclerosis - a survey focusing neurologists in daily practise.
Mult Scler Relat Disord
; 63: 103828, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35490449
13.
Development and evaluation of evidence-based patient information handbooks about multiple sclerosis immunotherapies.
Mult Scler Relat Disord
; 60: 103728, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35290898
14.
Implementation study of the 2021 German guideline for diagnosis and treatment of multiple sclerosis.
Mult Scler Relat Disord
; 57: 103434, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34920249
15.
[Progressive multifocal leukoencephalopathy under natalizumab. Initial possibilities for risk stratification?]. / Progressive multifokale Leukenzephalopathie unter Natalizumab. Erste Möglichkeiten einer Risikostratifizierung?
Nervenarzt
; 82(4): 475-80, 2011 Apr.
Artigo
em Alemão
| MEDLINE | ID: mdl-21240604
16.
Effects of disease-modifying therapy on peripheral leukocytes in patients with multiple sclerosis.
J Neurol
; 268(7): 2379-2389, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32036423
17.
[The critically ill CAR T-cell patient : Relevant toxicities, their management and challenges in critical care]. / Der kritisch kranke Patient nach CAR-T-Zell-Therapie : Relevante Nebenwirkungen, deren Management und Herausforderungen an die Intensivmedizin.
Med Klin Intensivmed Notfmed
; 116(2): 121-128, 2021 Mar.
Artigo
em Alemão
| MEDLINE | ID: mdl-33564900
18.
[Interferon ß for multiple sclerosis. How much is good enough?]. / Interferon ß bei Multipler Sklerose. Wie viel ist gut genug?
Nervenarzt
; 81(12): 1476-82, 2010 Dec.
Artigo
em Alemão
| MEDLINE | ID: mdl-21104222
19.
[Possibilities and risks of the monoclonal antibody alemtuzumab as a new treatment option for multiple sclerosis]. / Alemtuzumab als neue Therapieoption der Multiplen Sklerose : Hoffnung und Risiken beim Einsatz des monoklonalen Antikörpers.
Nervenarzt
; 80(4): 468-74, 2009 Apr.
Artigo
em Alemão
| MEDLINE | ID: mdl-19296065
20.
[Progressive multifocal leukoencephalopathy. Undesirable side effect of immunotherapy]. / Progressive multifokale Leukenzephalopathie. Unerwünschte Nebenwirkung einer Immuntherapie.
Nervenarzt
; 80(10): 1143-4, 1146-8, 1150-3, 2009 Oct.
Artigo
em Alemão
| MEDLINE | ID: mdl-19357826